(Q41119393)

27 September 2017

1 reference

title

Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty (English)

1 reference

27 September 2017

1 reference

Boston DR

1

1 reference

27 September 2017

Malouf A

series ordinal

2

1 reference

27 September 2017

Barry WH

series ordinal

3

1 reference

27 September 2017

1 July 1996

1 reference

27 September 2017

1 reference

27 September 2017

19

1 reference

27 September 2017

7

1 reference

27 September 2017

536-542

1 reference

Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty

27 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Experience with the Gianturco-Roubin stent for abrupt vessel closure complicating percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Results of intracoronary stents for management of coronary dissection after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Angioscopic versus angiographic detection of thrombus during coronary interventional procedures

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Arterial responses to balloon coronary angioplasty: an intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Angiographic morphology of coronary artery stenoses in prolonged rest angina: evidence of intracoronary thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Detection of intraarterial thrombus by intravascular high frequency two-dimensional ultrasound imaging in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Coronary arteriographic lesion of unstable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

The use of activated clotting times to monitor heparin therapy during and after interventional procedures

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Activated clotting-time variability in patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Preprocedural anticoagulation does not reduce angioplasty heparin requirements

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Adjunctive thrombolytic therapy for angioplasty in ischemic rest angina: results of a double-blind randomized pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Safety and efficacy of urokinase during elective coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

EPILOG and CAPTURE trials halted because of positive interim results

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Influence of contrast media on thrombus formation during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Regional myocardial blood flow with a reperfusion catheter and an autoperfusion balloon catheter during total coronary occlusion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Benefit of the perfusion catheter for emergency coronary artery grafting after failed percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Transcatheter aspiration of intracoronary thrombus after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190704

7 January 2021

Identifiers

DOI

10.1002/CLC.4960190704

1 reference

release_xniygmdwznblhb5dfkewv3cwyi

27 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xniygmdwznblhb5dfkewv3cwyi

24 November 2022

mapped directly with Wikidata item

1 reference